Table 5.
Comparator recommendation statements
| Mean | sd | % rated ≥ 7·0 | |
|---|---|---|---|
| 1. The choice of control condition should be clearly explained and justified. | 9·28 | 0·99 | 100 |
| 2. Prioritise the use of placebo or best-practice comparators over waitlist controls. | 7·56 | 2·59 | 72 |
| 3. In dietary interventions, when achieving effective blinding is challenging, attempt to match expectancy and engagement in the intervention and control. | 8·50 | 1·61 | 89 |
| 4. For interventions involving nutraceuticals or foods, the placebo should be matched in appearance, taste, smell, and packaging. | 7·83 | 2·19 | 83 |
| 5. Consider employing placebo diets and rigorously reviewing trial materials to sustain blinding. | 7·72 | 2·76 | 83 |
| 6. Consider use of non-inferiority trial designs to compare Nutritional Psychiatry interventions to currently recommended treatments (e.g. cognitive behavioural therapy, pharmacotherapy). | 7·67 | 2·60 | 78 |